ENXTPA:ERFLife Sciences
Did Stronger Earnings, Higher Dividend and Buybacks Just Shift Eurofins Scientific's (ENXTPA:ERF) Investment Narrative?
Eurofins Scientific SE recently reported its full-year 2025 results, with sales of €7,296 million and net income of €475 million, alongside higher basic and diluted earnings per share from continuing operations versus the prior year.
The company also signalled confidence by proposing a 20% higher annual dividend of €0.72 per share and completing a €184.14 million share buyback, while continuing to invest in AI-driven laboratory innovation and digital initiatives.
We will now look at how...